novelty pharma gdd sa
الجدة فارما - Innovazione Farmaceutica Effervescente
الابتكار الصيدلاني الفوار مزيد من المعلومات عن الشركة نقوم بتطوير المنتجات الصيدلانية والمكملات الغذائية منذ أكثر من 25 عامًا. نحن مركز للتميز في قطاع الرعاية الصحية، متخصصون في الأدوية والتغذية ومستحضرات التجميل، ورسالتنا هي: استشراف المستقبل. بفضل اهتمامنا المستمر باتجاهات السوق، فإننا نقود الابتكار ونصنع منتجات متطورة
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cadempino, Switzerland
- Website
- https://www.noveltypharma.com
- Categories
- تصنيع الأدوية, اللوازم الطبية والرعاية الصحية, المكملات الغذائية والعافية
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-07-21 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)